DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors. Chung JS, Ramani V, Kobayashi M, Fattah F, et al. Clin Cancer Res 2020;26:1449-1459.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chung JS, Ramani V, Kobayashi M, Fattah F, et al. DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors. Clin Cancer Res 2020;26:1449-1459.
PMID: 31822499